Herantis Pharma Oyj
A clinical-stage biotech developing therapies for neurodegenerative diseases like Parkinson's.
HRTIS | ST
Overview
Corporate Details
- ISIN(s):
- FI4000087861
- LEI:
- 743700W4CQVYAT3WKK38
- Country:
- Finland
- Address:
- Bertel Jungin Aukio 1, FI-02600 ESPOO
- Website:
- https://herantis.com/
Description
Herantis Pharma is a clinical-stage biotechnology company dedicated to developing disease-modifying therapies for neurodegenerative conditions, with a primary focus on Parkinson's disease. The company's research is centered on its proprietary technology platform based on the cerebral dopamine neurotrophic factor (CDNF), which aims to stop or reverse disease progression. Its lead product candidate, HER-096, is a synthetic peptide engineered to cross the blood-brain barrier and address the underlying proteopathic mechanisms of the disease. The company's mission is to address significant unmet medical needs by creating innovative treatments for debilitating neurological disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Herantis Pharma Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Herantis Pharma Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Herantis Pharma Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
